Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Conditions
- Pancreatic Cancer
- Melanoma
- Squamous Cell Carcinoma of the Head and Neck
- Prostate Cancer
Interventions
- DRUG: Evofosfamide
- DRUG: Ipilimumab
Sponsor
Threshold Pharmaceuticals
Collaborators